Carlos Crespo

910 total citations
65 papers, 583 citations indexed

About

Carlos Crespo is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carlos Crespo has authored 65 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 13 papers in Cardiology and Cardiovascular Medicine and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carlos Crespo's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Carlos Crespo is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers). Carlos Crespo collaborates with scholars based in Spain, Switzerland and France. Carlos Crespo's co-authors include Max Brosa, Marc Miravitlles, A. López-Alba, Bernat Soria, Walter Díaz, Toni Monleón-Getino, Carles Forné, Alicia Huerta, Julia Álvarez Hernández and José Manuel Rodríguez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and The Laryngoscope.

In The Last Decade

Carlos Crespo

57 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Crespo Spain 13 145 95 89 89 76 65 583
Kay Larholt United States 11 118 0.8× 65 0.7× 59 0.7× 112 1.3× 122 1.6× 25 1.2k
Edith Poku United Kingdom 16 143 1.0× 49 0.5× 59 0.7× 37 0.4× 76 1.0× 38 681
B.M.K. Donato United States 12 147 1.0× 108 1.1× 99 1.1× 25 0.3× 74 1.0× 47 660
Elizabeth H. Jones United Kingdom 12 202 1.4× 57 0.6× 106 1.2× 214 2.4× 57 0.8× 39 1.2k
Shiva Sajjan United States 17 222 1.5× 42 0.4× 67 0.8× 263 3.0× 61 0.8× 37 829
Else Helene Ibfelt Denmark 16 89 0.6× 33 0.3× 105 1.2× 53 0.6× 42 0.6× 33 664
Richard Phoon Australia 12 83 0.6× 41 0.4× 61 0.7× 38 0.4× 33 0.4× 27 610
Steven Oliver United Kingdom 19 318 2.2× 174 1.8× 102 1.1× 59 0.7× 85 1.1× 33 1.0k
Lynn Robertson United Kingdom 14 52 0.4× 106 1.1× 133 1.5× 115 1.3× 70 0.9× 25 943
Anneke Kramer Netherlands 18 94 0.6× 45 0.5× 59 0.7× 32 0.4× 110 1.4× 46 784

Countries citing papers authored by Carlos Crespo

Since Specialization
Citations

This map shows the geographic impact of Carlos Crespo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Crespo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Crespo more than expected).

Fields of papers citing papers by Carlos Crespo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Crespo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Crespo. The network helps show where Carlos Crespo may publish in the future.

Co-authorship network of co-authors of Carlos Crespo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Crespo. A scholar is included among the top collaborators of Carlos Crespo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Crespo. Carlos Crespo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez-Ruiz, Fernando, et al.. (2024). Cost-effectiveness analysis of subcutaneous biosimilar tocilizumab in patients with rheumatoid arthritis in Spain. Farmacia Hospitalaria. 49(5). 278–285.
2.
Mestre-Ferrándiz, Jorge, et al.. (2024). Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain. BMC Infectious Diseases. 24(1). 779–779. 1 indexed citations
3.
Pozo‐Rosich, Patricia, et al.. (2024). Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis. The Journal of Headache and Pain. 25(1). 40–40. 6 indexed citations
4.
Valerio, Maricela, Carmen Rodríguez, Sofía de la Villa, et al.. (2023). Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS. Journal of Medical Economics. 26(1). 463–472. 5 indexed citations
5.
Carrera‐Hueso, Francisco Javier, et al.. (2021). Hospitalization budget impact during the COVID-19 pandemic in Spain. Health Economics Review. 11(1). 43–43. 18 indexed citations
6.
Vicente, Vicente, Alfonso Martı́n, Pascual Marco, et al.. (2017). Perspectivas clínicas del manejo de la hemorragia en el paciente tratado con anticoagulante oral: estudio DECOVER. Emergencias. 29(1). 18–26.
7.
Borgström, Fredrik, et al.. (2015). Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain. Value in Health. 18(7). A501–A501. 1 indexed citations
8.
Hernández, Julia Álvarez, et al.. (2015). Análisis coste-efectividad del cribado universal de la enfermedad tiroidea en mujeres embarazadas en España. Endocrinología y Nutrición. 62(7). 322–330. 19 indexed citations
9.
Crespo, Carlos, et al.. (2014). Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies. BMC Medical Research Methodology. 14(1). 139–139. 43 indexed citations
10.
Calaf, Joaquím, et al.. (2014). Cost-effectiveness analysis in the treatment of heavy menstrual bleeding in Spain. European Journal of Obstetrics & Gynecology and Reproductive Biology. 184. 24–31. 1 indexed citations
11.
Seguí, Miguel Ángel, Carlos Crespo, Javier Cortés, et al.. (2014). Genomic profile of breast cancer: cost–effectiveness analysis from the Spanish National Healthcare System perspective. Expert Review of Pharmacoeconomics & Outcomes Research. 14(6). 889–899. 16 indexed citations
12.
Crespo, Carlos, et al.. (2013). Direct Cost of Diabetes Mellitus and Its Complications in Spain. Seccaid Study: Spain Estimated Cost Ciberdem-Cabimer in Diabetes. Value in Health. 16(7). A436–A436. 12 indexed citations
13.
14.
Donnay, Sergio, et al.. (2013). Carga de la enfermedad atribuible al hipotiroidismo subclínico en la población española. Revista Clínica Española. 213(8). 363–369. 5 indexed citations
15.
Crespo, Carlos, et al.. (2012). [The social cost of depression in the city of Sabadell (Barcelona, Spain) (2007-2008)].. PubMed. 26(2). 153–8. 3 indexed citations
16.
17.
18.
Crespo, Carlos, et al.. (2011). The use of cost per life year gained as a measurement of cost-effectiveness in Spain: a systematic review of recent publications. The European Journal of Health Economics. 13(6). 723–740. 26 indexed citations
19.
Crespo, Carlos, Max Brosa, Jordi Galván, et al.. (2010). Análisis farmacoeconómico de Metoject® en el tratamiento de la artritis reumatoide en España. Reumatología Clínica. 6(4). 203–211. 7 indexed citations
20.
Moreu, José, Ángel Cequier, Max Brosa, et al.. (2009). Evaluación económica e impacto presupuestario del stent recubierto Endeavor® en España. Hispana. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kay Larholt Breakdown of academic impact, for papers by Edith Poku Breakdown of academic impact, for papers by B.M.K. Donato Breakdown of academic impact, for papers by Elizabeth H. Jones Breakdown of academic impact, for papers by Shiva Sajjan Breakdown of academic impact, for papers by Else Helene Ibfelt Breakdown of academic impact, for papers by Richard Phoon Breakdown of academic impact, for papers by Steven Oliver Breakdown of academic impact, for papers by Lynn Robertson Breakdown of academic impact, for papers by Anneke Kramer
Rankless by CCL
2026